GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LabGenomics Co Ltd (XKRX:084650) » Definitions » EV-to-Revenue

LabGenomics Co (XKRX:084650) EV-to-Revenue : 1.97 (As of Jun. 03, 2025)


View and export this data going back to 2013. Start your Free Trial

What is LabGenomics Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, LabGenomics Co's enterprise value is ₩173,076 Mil. LabGenomics Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₩87,884 Mil. Therefore, LabGenomics Co's EV-to-Revenue for today is 1.97.

The historical rank and industry rank for LabGenomics Co's EV-to-Revenue or its related term are showing as below:

XKRX:084650' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.03   Med: 2.35   Max: 9.72
Current: 1.97

During the past 13 years, the highest EV-to-Revenue of LabGenomics Co was 9.72. The lowest was 0.03. And the median was 2.35.

XKRX:084650's EV-to-Revenue is ranked better than
64.59% of 209 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.75 vs XKRX:084650: 1.97

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), LabGenomics Co's stock price is ₩2750.00. LabGenomics Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩1,177.76. Therefore, LabGenomics Co's PS Ratio for today is 2.33.


LabGenomics Co EV-to-Revenue Historical Data

The historical data trend for LabGenomics Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LabGenomics Co EV-to-Revenue Chart

LabGenomics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.39 0.91 0.69 3.11 1.68

LabGenomics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.20 1.25 2.31 1.68 1.44

Competitive Comparison of LabGenomics Co's EV-to-Revenue

For the Diagnostics & Research subindustry, LabGenomics Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LabGenomics Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LabGenomics Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where LabGenomics Co's EV-to-Revenue falls into.


;
;

LabGenomics Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

LabGenomics Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=173075.938/87884.265
=1.97

LabGenomics Co's current Enterprise Value is ₩173,076 Mil.
LabGenomics Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩87,884 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LabGenomics Co  (XKRX:084650) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

LabGenomics Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2750.00/1177.757
=2.33

LabGenomics Co's share price for today is ₩2750.00.
LabGenomics Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,177.76.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LabGenomics Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of LabGenomics Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LabGenomics Co Business Description

Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, 6F-B, Bundang-gu, Korea Bio Park Building, Gyeonggi-do, Seongnam, KOR, 463-400
LabGenomics Co Ltd is a healthcare company. The Company operates in three business divisions namely NGS, Diagnostic service, IVD products. NGS offers mom guard, cancer panel, Predisposition panel and PGS; Diagnostic service provides esoteric tests such as cancer genetics, genetic disorder. Whereas IVD products include DNA chips, PCR kit among others.

LabGenomics Co Headlines

No Headlines